EAACI Congress 2025
BackLong-Term Prophylactic Treatment With Oral Deucrictibant Improves Disease Control and Health-Related Quality of Life in Participants With Hereditary Angioedema in the CHAPTER-1 Open-Label Extension Study
12:07 PM - 12:14 PM Your local time